Healthcare -
Biotechnology - NASDAQ - US
$ 0.7556
-7.85 %
$ 4.11 M
Market Cap
-0.01
P/E
ALZN - CASH & EQUIVALENTS
Cash & Equivalents ALZN - Alzamend Neuro, Inc.
376 K
LAST VALUE
-83.65%
2 YEAR CAGR
54.58%
5 YEAR CAGR
0.00%
10 YEAR CAGR